Nasus Pharma Ltd (NSRX) › Weighted Average Diluted SharesNasus Pharma Ltd (NSRX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2023-12-31: 7.06M2024-12-31: 7.03M2025-12-31: 8.01M8.01M2023-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-318.01M+14.0%2026-03-25From 2025-01-012024-12-317.03M-0.4%2026-03-25From 2024-01-012023-12-317.06M—2026-03-25From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)